CLINICAL_TRIALS
trial_result
· 2012-06-08
Clinical Trial Update: Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma [Phase 3]
Summary
Phase 3 clinical trial results evaluate omalizumab in patients with severe persistent non-atopic uncontrolled asthma. The results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2012-06-08